CClinicalTrials.gg
CompletedNCT05052164Updated Sep 22, 2021

Improvement Of Physical And Physiological Parameters In Menopausal Or Post-Menopausal Celiac Women

An interventional study of Gluten-free nutrition plan + exercise group and Gluten-free nutrition plan group in Celiac Disease, Diet, Gluten-Free and Exercise, sponsored by University of Alicante. Completed at 1 site in Spain. Open to female participants aged 40 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-09-22.

Sponsored by University of Alicante · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 3 years after the study started (first participant enrolled Sep 2018, registered Sep 2021).
Phase
Not applicable
Study type
Interventional
Enrollment
28
Allocation
Randomized
Ages
40 Years to 70 Years
Sex
Female
01

Study summary

Celiac disease (CD) is an immunological disorder that mainly affects the small intestine, generating an inflammatory process in response to the presence of gluten (a protein). Autoimmune diseases are part of a group of diseases that are difficult to diagnose without a specific protocol or consensus to detect them due to the number of symptoms and diseases with which it has a relationship. The incidence of CD in Spain -according to data from the rest of the European Economic Community, since there is no study on incidence in Spain- is assumed to be approximately 1 per 100 live births. It is more frequent in women, with a 2:1 ratio. The only treatment consists of a STRICT GLUTEN-FREE DIET FOR LIFE. This results in the disappearance of symptoms, normalization of serology and recovery of intestinal villi. Failure to follow the diet can lead to important complications which, especially in adulthood, can manifest themselves in the form of osteopenia, osteoporosis and a high risk of neoplasms in the digestive tract, mainly. The main objective is to achieve a physical and physiological improvement in menopausal or post-menopausal celiac women. The specific objectives will be to know the influence of a dietary-nutritional program combined with physical exercise in menopausal or post-menopausal celiac women on:

  • Physical condition (strength, endurance, functional autonomy...).
  • Body composition.
  • Psychological aspects.
  • Physiological parameters (heart rate, maximum oxygen consumption, blood analysis...).
02

Conditions studied

  • Celiac Disease
  • Diet, Gluten-Free
  • Exercise
  • Resistance Training
  • Quality of Life
  • Body Composition

Browse trials for

03

In context

Celiac Disease

333 studies on the registry are indexed under Celiac Disease; 77 are open to participants now.

This study's enrollment of 28 is below the median of 50 across 203 interventional studies indexed under Celiac Disease.

Browse Celiac Disease studies →

Lead sponsor

University of Alicante is the lead sponsor of 27 studies on the registry; 7 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years to 70 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • Women
  • Over 40 years old
  • Menopausal or post-menopausal women
  • Women with celiac disease (in the case of the experimental groups)

Exclusion criteria

Exclusion Criteria:

  • Men
  • Women of childbearing age
  • Women \< 40 years old
  • Failure to sign informed consent form
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
28 participants (actual)

Study arms

  • Experimental
    Gluten-free nutrition plan + exercise group

    Celiac women who perform a physical exercise program 3/4 times per week and a gluten-free isocaloric dietary plan.

    Behavioral: Gluten-free nutrition plan + exercise group

  • Experimental
    Gluten-free nutrition plan group

    Women with celiac disease following a gluten-free isocaloric dietary plan.

    Behavioral: Gluten-free nutrition plan group

  • Active comparator
    Celiac controls group

    Women with celiac disease in whom all variables are measured but no intervention is performed.

    Behavioral: Active Comparator: Celiac controls group

  • No intervention
    Non-celiac controls group

    Non celiac menopausal or post-menopausal in whom all the tests were measured but they did not perform an intervention program with physical exercise or special follow-up of an adapted dietary-nutritional program

Interventions

  • BehavioralGluten-free nutrition plan + exercise group

    Menopausal or post-menopausal celiac women will follow a physical exercise program 3/4 times per week and their dietary intake will be gluten-free isocaloric

  • BehavioralGluten-free nutrition plan group

    Menopausal or post-menopausal celiac women will follow a gluten-free isocaloric dietary program

  • BehavioralActive Comparator: Celiac controls group

    Menopausal or post-menopausal celiac women in whom all the tests were measured but they did not perform an intervention program with physical exercise or special follow-up of an adapted dietary-nutritional program

06

What researchers measure

Primary outcomes

  1. Quality of Life (QoL)

    A QoL questionnaire was performed; the WHOQOL-BREF of the World Health Organization

    Time frame: 12 weeks

  2. Body Composition - Fat Mass

    Evaluation of body fat by bioimpedance.

    Time frame: 12 weeks

  3. Body Composition - Lean Body Mass

    Evaluation of lean body mass by bioimpedance.

    Time frame: 12 weeks

  4. Body Composition - Visceral Fat

    Evaluation of visceral fat by bioimpedance.

    Time frame: 12 weeks

  5. Weight

    Weight evaluation using a digital scale

    Time frame: 12 weeks

  6. Strength

    A calibrated handgrip dynamometer (Takei 5101, Tokyo, Japan) measure isometric grip strength (HGS)

    Time frame: 12 weeks

  7. Adherence to gluten-free diet

    Questionnaire "Adherence to gluten-free diet" was performed.

    Time frame: 12 weeks

  8. Anthropometric assessment - Skinfolds

    Restricted profile proposed by the International Society for the Development of Cineanthropometry was carried out.

    Time frame: 12 weeks

  9. Anthropometric assessment - Perimeters

    Restricted profile proposed by the International Society for the Development of Cineanthropometry was carried out.

    Time frame: 12 weeks

  10. Anthropometric assessment - Diameters

    Restricted profile proposed by the International Society for the Development of Cineanthropometry was carried out.

    Time frame: 12 weeks

  11. Anthropometric assessment - Height

    Restricted profile proposed by the International Society for the Development of Cineanthropometry was carried out.

    Time frame: 12 weeks

  12. Resistance test

    6-minute walk test. This test is an adaptation of the Rikli and Jones (1998) test.

    Time frame: 12 weeks

  13. Balance test

    By means of the PSYMTEC® contact platform, which act as switches and are useful for recording contact times between supports.

    Time frame: 12 weeks

  14. Functional autonomy test

    GDLAM protocol

    Time frame: 12 weeks

  15. State of mind

    Evaluation by using the Profile of Mood States POMS questionnaire.

    Time frame: 12 weeks

  16. Eating disorders

    Eating disorders questionnaire: Eating Attitudes Test Questionnaire (EAT) in its 26-item version (EAT-26) in Spanish (Rivas et al., 2010).

    Time frame: 12 weeks

  17. Heart rate variability

    Using novel Firstbeat Bodyguard device (Föhr, 2016)

    Time frame: 12 weeks

  18. Maximum oxygen consumption

    Heart rate measurement and recording with Firsbeat Bodyguard

    Time frame: 12 weeks

  19. Glucose in blood

    Glucose by blood test

    Time frame: 12 weeks

  20. Cholesterol in blood

    Cholesterol by blood test

    Time frame: 12 weeks

  21. Creatinine in blood

    Creatinine by blood test

    Time frame: 12 weeks

  22. Urea in blood

    Urea by blood test

    Time frame: 12 weeks

07

Study locations

1 site
  • University of Alicante
    Alicante, San Vicente Del Raspeig 03690, Spain
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 22, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05052164
Lead sponsor
University of Alicante
Responsible party
Prof. Dr. Alejandro Martínez-Rodríguez (Assistant Professor, University of Alicante) — Principal investigator
First posted
Sep 22, 2021
Start date
Sep 1, 2018
Primary completion
Aug 1, 2021
Completion
Sep 1, 2021
Last update
Sep 22, 2021

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion